ArticleBlood2023
High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients.
Abstract read
In one paragraph
Article in Blood, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee.Blood cancer journal · 2025Article
- COVID-19 and CLL in Sweden: lessons learned?Blood advances · 2025Article
- Monoclonal B-Cell Lymphocytosis: The Silent Clone the Haematologists Should Not Neglect.Hematological oncology · 2025Review
- Early Immune Cell and Antibody Kinetics Following SARS-CoV-2 Vaccination in Healthy Adults and Low-Count Monoclonal B-Cell Lymphocytosis.International journal of molecular sciences · 2025Article
- Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study.Blood cancer journal · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Guillermo Oliva-ArizaTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.ORCID 0000-0002-9653-9849
Blanca Fuentes-HerreroTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.ORCID 0000-0002-4038-8439
Cristina CarbonellInstitute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID 0000-0002-6271-5111
Quentin LecrevisseTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.ORCID 0000-0001-8715-5846
Alba Pérez-PonsTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.ORCID 0000-0002-5805-1391
Alba Torres-ValleTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.
Julio PozoTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.
José Ángel Martín-OterinoInstitute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID 0000-0002-5598-5180
Óscar González-LópezTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.ORCID 0000-0002-4169-4294
Amparo López-BernúsInstitute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID 0000-0002-7524-4056
Marta Bernal-RibesTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.
Moncef Belhassen-GarcíaInstitute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID 0000-0002-2230-1256
Oihane Pérez-EscurzaTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.
Martín Pérez-AndrésTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.
Lourdes VazquezInstitute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Guillermo Hernández-PérezDepartment of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.ORCID 0000-0001-8610-5425
Francisco Javier García PalomoSpanish National DNA Bank Carlos III, University of Salamanca, Salamanca, Spain.ORCID 0000-0003-3974-0308
Pilar LeozInstitute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Pilar Costa-AlbaInstitute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID 0000-0001-5677-9066
Elena Pérez-LosadaInstitute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID 0000-0001-8205-5344
Ana YeguasInstitute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Miryam Santos SánchezTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.ORCID 0000-0003-3129-1712
Marta García-BlázquezDepartment of Hematology, University Hospital of Salamanca, Salamanca, Spain.
Francisco Javier Morán-PlataTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.
Daniela DamascenoTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.
Vitor BotafogoTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.
Noemí Muñoz-GarcíaTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.ORCID 0000-0002-8381-301X
Rafael FluxaCytognos SL, Salamanca, Spain.
Teresa Contreras-SanfelicianoDepartment of Biochemistry, University Hospital of Salamanca, Salamanca, Spain.
Julia AlmeidaTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.ORCID 0000-0003-3124-8917
Miguel MarcosInstitute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID 0000-0003-1269-4487
Alberto OrfaoTranslational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19Leukemia, Lymphocytic, Chronic, B-CellLymphocytosisNeoplasms, Plasma CellB-LymphocytesHumansLymphocyte Count
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.